Want to see SE:MYCR full AI Analyst Report?
Top Page
Mycronic AB
(MYCR)
Select Model
Select Model
Rating:73Outperform
Price Target:
kr378.00
▲(13.79% Upside)
Action:Upgraded
Date:07/15/26
The score is primarily driven by strong financial performance—high margins, strong ROE, and very low leverage—partly tempered by recent free-cash-flow inconsistency. Technicals are supportive on longer-term trend (price above major moving averages) but show softer near-term momentum (negative MACD). Valuation is a notable headwind given the high P/E and modest yield.
Positive Factors
High Profitability / Margins
Sustained high gross, EBIT and net margins indicate durable operational efficiency in capital equipment and services. Strong margins support internal reinvestment, steady profitability through cycles and the ability to fund R&D or service expansion without relying on external financing.
Negative Factors
Inconsistent Free Cash Flow
Material decline in free cash flow versus the prior period, despite healthy operating cash flow, signals volatility in cash conversion. Inconsistent FCF can limit reliable capital allocation, make dividend/share-buyback planning harder and constrain funding for cyclical investments or R&D.
Read all positive and negative factors
Positive Factors
Negative Factors
High Profitability / Margins
Sustained high gross, EBIT and net margins indicate durable operational efficiency in capital equipment and services. Strong margins support internal reinvestment, steady profitability through cycles and the ability to fund R&D or service expansion without relying on external financing.
Read all positive factors
Mycronic AB (MYCR) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr62.43B
Dividend Yield1.01%
Average Volume (3M)215.48K
Price to Earnings (P/E)36.0
Beta (1Y)0.90
Revenue Growth7.48%
EPS Growth-12.10%
CountrySE
Employees2,772
SectorGeneral
Sector StrengthN/A
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)8.89
Shares Outstanding195,833,020
10 Day Avg. Volume255,261
30 Day Avg. Volume215,484
Financial Highlights & Ratios
PEG Ratio-3.77
Price to Book (P/B)6.13
Price to Sales (P/S)5.49
P/FCF Ratio33.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)10.33
Revenue Forecast (FY)kr9.39B
Mycronic AB Business Overview & Revenue Model
Company Description
Mycronic AB (publ), based in Täby, Sweden, is a global entity dedicated to the creation, production, and sale of advanced manufacturing machinery for the electronics sector. The company operates extensively across Sweden, wider Europe, North and S...
How the Company Makes Money
Mycronic makes money primarily by selling capital equipment (large, high-value production systems) and by generating recurring revenue from services and aftermarket sales tied to its installed base. Key revenue streams include: (1) Equipment sales...
Mycronic AB Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
90
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.65B | 7.94B | 7.06B | 5.71B | 5.12B | 4.63B |
| Gross Profit | 4.57B | 4.12B | 3.72B | 2.72B | 2.29B | 2.28B |
| EBITDA | 2.67B | 2.30B | 2.32B | 1.39B | 1.11B | 1.20B |
| Net Income | 1.74B | 1.56B | 1.68B | 998.00M | 741.00M | 828.00M |
Balance Sheet | ||||||
| Total Assets | 12.30B | 10.92B | 10.41B | 8.34B | 7.34B | 6.14B |
| Cash, Cash Equivalents and Short-Term Investments | 2.69B | 2.32B | 3.01B | 2.14B | 1.27B | 683.00M |
| Total Debt | 420.00M | 348.00M | 219.00M | 228.00M | 270.00M | 243.00M |
| Total Liabilities | 4.41B | 3.81B | 3.84B | 3.06B | 2.64B | 2.14B |
| Stockholders Equity | 7.88B | 7.11B | 6.53B | 5.25B | 4.66B | 3.96B |
Cash Flow | ||||||
| Free Cash Flow | 999.00M | 1.32B | 1.64B | 1.41B | 712.00M | 908.00M |
| Operating Cash Flow | 2.05B | 1.41B | 1.87B | 1.61B | 853.00M | 998.00M |
| Investing Cash Flow | -448.00M | -1.13B | -500.00M | -195.00M | 67.00M | -1.22B |
| Financing Cash Flow | -772.00M | -862.00M | -552.00M | -447.00M | -382.00M | -437.00M |
Mycronic AB Technical Analysis
Positive
332.20
Price Trends
321.67
Negative
310.30
Positive
260.92
Positive
Market Momentum
-1.34
Positive
49.07
Neutral
46.84
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MYCR, the sentiment is Positive. The current price of 332.2 is above the 20-day moving average (MA) of 320.67, above the 50-day MA of 321.67, and above the 200-day MA of 260.92, indicating a neutral trend. The MACD of -1.34 indicates Positive momentum. The RSI at 49.07 is Neutral, neither overbought nor oversold. The STOCH value of 46.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:MYCR.
Mycronic AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | kr481.68B | 28.68 | 17.52% | 1.56% | 6.31% | 16.31% | |
73 Outperform | kr62.43B | 36.04 | 23.33% | 1.01% | 7.48% | -12.10% | |
73 Outperform | kr938.83B | 37.14 | 23.93% | 1.69% | -1.80% | -5.25% | |
72 Outperform | kr225.51B | 27.64 | 18.42% | 1.64% | 3.87% | 2.11% | |
57 Neutral | kr4.48B | 18.25 | ― | 3.14% | -5.51% | -14.52% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
50 Neutral | kr27.12B | 52.68 | 10.02% | 1.09% | -4.33% | 38.59% |
* General Sector Average
SE:MYCR
Mycronic AB
320.40
110.86
52.90%
SE:ALFA
Alfa Laval AB
548.20
116.21
26.90%
SE:ATCO.B
Atlas Copco AB
175.15
38.62
28.28%
SE:SAND
Sandvik AB
385.20
139.11
56.53%
SE:MTRS
Munters Group AB
147.30
22.40
17.94%
SE:NMAN
Nederman Holding AB
127.40
-32.94
-20.54%
Mycronic AB Corporate Events
Mycronic lifts 2026 sales outlook as record orders fuel AI-driven demand
Jul 14, 2026
Mycronic AB delivered a strong second quarter in 2026, with order intake surging 119 percent year-on-year to a record SEK 2,917 million and net sales rising 17 percent to SEK 2,416 million, lifting the EBIT margin to 29 percent and earnings per sh...
Mycronic Schedules Capital Markets Day to Deepen Investor Engagement
Jul 3, 2026
Mycronic AB has invited analysts, institutional investors and media to a Capital Markets Day at its Täby premises on August 31, 2026, with a program running from early afternoon and limited on-site attendance. The event, which will also be ac...
Mycronic schedules Q2 2026 webcast to brief investors and analysts
Jun 30, 2026
Mycronic has invited analysts, investors and media to follow its presentation of the second-quarter 2026 results via an English-language webcast on July 14, 2026. The Q2 report will be published that morning and made available alongside the webcas...
Mycronic Wins Asian Order for SLX Semiconductor Mask Writer
Jun 30, 2026
Mycronic has secured an order from an existing Asian customer for its SLX laser mask writer, a system valued between USD 5 million and USD 7 million and scheduled for delivery in the third quarter of 2026. The deal underscores growing demand for m...
Mycronic wins new SLX mask writer order from Asian semiconductor customer
Jun 25, 2026
Mycronic AB has secured an order worth between USD 5 million and 7 million for its SLX laser mask writer from an existing customer in Asia, with delivery scheduled for the fourth quarter of 2026. The deal underscores continued investment in laser-...
Mycronic Wins New European Order for SLX Semiconductor Mask Writer
Jun 15, 2026
Mycronic’s Pattern Generators division, which supplies mask writers and metrology systems for display and semiconductor manufacturing, has secured a new European customer for its SLX laser mask writer in a deal valued between USD 6 million a...
Mycronic AGM Backs Dividend, Share Issuance Mandate and New Incentive Plan
May 6, 2026
Mycronic’s annual general meeting in Täby approved the 2025 financial statements, set a dividend of SEK 3.25 per share and granted discharge from liability to the board and CEO, underscoring continued confidence in the company’s g...
Mycronic Lifts 2026 Sales Target After Record First-Quarter Earnings
Apr 24, 2026
Mycronic opened 2026 with record quarterly performance, as order intake rose 23 percent to SEK 2,529 million and net sales climbed 17 percent to SEK 2,503 million, or 32 percent at constant exchange rates. EBIT reached an all-time high of SEK 938 ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.